Reply to thread

Message: [QUOTE="greenmedinfo, post: 1213"] PMID: Toxicol Rep. 2021 ;8:1803-1813. Epub 2021 Oct 25. PMID: 34760624 Abstract Title: Naringin prevents cyclophosphamide-induced erythrocytotoxicity in rats by abrogating oxidative stress. Abstract: Earlier reports have shown that Cyclophosphamide (CYCP), an anti-malignant drug, elicited cytotoxicity; and that naringin has several beneficial potentials against oxidative stress and dyslipidaemias. We investigated the influence of naringin on free radical scavenging, cellular integrity, cellular ATP, antioxidants, oxidative stress, and lipid profiles in the CYCP-induced erythrocytotoxicity rat model. Rats were pretreated orally by gavage for fourteen consecutive days with three doses (50, 100, and 200 mg/kg) naringin before single CYCP (200 mg/kg, i.p.) administration. Afterwards, the rats were sacrificed. Naringin concentrations required for 50 % scavenging hydrogen peroxide and nitric oxide radical were 0.27 mg/mL and 0.28 mg/mL, respectively. Naringin pretreatment significantly (p [URL='https://www.greenmedinfo.com/article/naringin-prevents-cyclophosphamide-induced-erythrocytotoxicity']read more[/URL] [/QUOTE]